eureKARE
Overview
eureKARE is an investment company focused on financing and developing synthetic biology innovation across Europe. Driven by the belief that synthetic biology holds the key to many of the world’s most …
Investment Focus
- Focus on synthetic biology and microbiome innovations
- Address health and environmental challenges
- Early-stage to growth-stage companies
Portfolio Companies
Reach eureKARE directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about eureKARE
What sectors does eureKARE invest in?
eureKARE invests in Healthcare, Biotechnology, Synthetic Biology, Environmental Sustainability and Microbiome, and is based in France. eureKARE is listed as a venture capital in the ConnectSafely investor database.
What stage does eureKARE invest at?
eureKARE backs companies at Seed, Early Stage and Growth, writing cheques of 500K - 5M.
Which regions does eureKARE invest in?
eureKARE invests across France, Luxembourg, Belgium and Monaco.
Who are the partners at eureKARE?
Team members listed for eureKARE include PAMPFER Serge (Chief Scientific Officer).
What companies has eureKARE invested in?
eureKARE's portfolio includes Biomemory.
How do I contact eureKARE?
eureKARE's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
